Clinical characteristics and outcome of current standard management of central retinal artery occlusion

Clinical and Experimental Ophthalmology

Volumn 38, Issue 5, 2010, Pages 496-501

  Rudkin, Adam K ^a   Lee, Andrew W ^b   Aldrich, Eric ^c   Miller, Neil R ^d   Chen, Celia S ^a  

^a NH and MRC Centre of Clinical Eye Research   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Complication; Inpatient; Management; Outpatient; Retinal artery occlusion; Visual acuity

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; OUTPATIENT; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; VISUAL ACUITY; ACUTE DISEASE; INCIDENCE; ISCHEMIA; MASSAGE; MIDDLE AGED; PARACENTESIS; PROCEDURES; RETINAL ARTERY OCCLUSION; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ANTIHYPERTENSIVE AGENT;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; INCIDENCE; INPATIENTS; ISCHEMIA; MALE; MASSAGE; MIDDLE AGED; OUTPATIENTS; PARACENTESIS; RETINAL ARTERY OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 77958094543     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02280.x     Document Type: Article

References (19)

1. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128: 733-8.
2. Chen CS, Lee AW. Management of acute central retinal artery occlusion. Nat Clin Pract Neurol 2008; 4: 376-83.
3. Schmidt D, Schumacher M, Feltgen N. Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol 2009; 247: 491-4.
4. Fraser SG, Adams W. Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database Syst Rev 2009; 1: CD001989.
5. Feltgen N, Neubauer A, Jurklies B et al. EAGLE-Study Group. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report No. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244: 950-6.
6. Aldrich EM, Lee AW, Chen CS et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke 2008; 39: 1746-50.
7. Arroyo JG, Postel EA, Stone T, McCuen BW, Egan KM. A matched study of primary scleral buckle placement during repair of posterior segment open globe injuries. Br J Ophthalmol 2003; 87: 75-8.
8. Atebara NH, Carter GC, Cater J. Efficacy of anterior chamber paracentesis and carbogen in treating acute nonarteric central retinal artery occlusion. Ophthalmology 1995; 102: 2029-35.
9. Karjalainen K. Occlusion of the central retinal artery and retinal branch arterioles. Acta Ophthalmol 1971; 109 (Suppl.): 1-96.
10. Mueller AJ, Meubauer AS, Schaller U, Kampik A. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121: 1377-81.
11. Douglas DJ, Schuler JJ, Buchbinder D, Dillon BC, Flanigan DP. The association of central retinal artery occlusion and extracranial carotid artery disease. Ann Surg 2008; 208: 85-90.
12. Sacco RL, Adams R, Albers G et al.; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113: 409-49.
13. Alberts MJ, Obviagele B. Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol 2007; 254: 1414-26.
14. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371: 1612-23.
15. Schmidt D, Hetzel A, Geibel-Zehender A, Schulte-Monting J. Systemic diseases in non-inflammatory branch and central retinal artery occlusion-an overview of 416 patients. Eur J Med Res 2007; 12: 595-603.
16. Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol 2008; 92: 588-93.
17. National Institute of Neurological Disease and Stroke (NINDS). Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-8.
18. Waters RE II, Mahaffey KW, Granger CB, Roe MT. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Am Heart J 2003; 146: 958-68.
19. Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 2008; 146: 700-6.